Columnist Ahna Crum, who's a practitioner in functional medicine, questioned herself when she had an unexpected MS relapse.

Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Researchers at the University of Pittsburgh and Carnegie Mellon University collaborated to create a customized app based on ...

Researchers at Oregon Health & Science University have identified a gene that plays a crucial role in the brain's ability to ...

Author Chris Bridges, who for years struggled with symptoms that felt like a ghost was touching him as he began to feel numb ...

Multiple sclerosis is the most prevalent chronic inflammatory disease of the central nervous system (CNS), affecting more than 2 million people worldwide (at least 400,000 in the United States), 1 ...

Carmen McCane's motivation is deeply personal. Her mother was diagnosed with MS, and as an avid runner, McCane saw an ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that ...

DelveInsight’s, “Multiple Sclerosis Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ ...

Selma Blair reveals multiple sclerosis diagnosis 03:18. Selma Blair revealed this week she was leaving "Dancing with the Stars" due to complications from multiple sclerosis.

Treatment Options for Multiple Sclerosis. This review focuses on the current knowledge of the pathogenesis of the inflammatory and neurodegenerative elements of the multiple sclerosis plaque. In ...

Multiple sclerosis (MS) is a chronic disease that affects your brain and spinal cord. When you have it, your immune system -- your body's defense against germs -- attacks the insulation, or myelin ...